My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Maternal gene effect in neurofibromatosis 2: fact or artefact?

    Baser ME, Friedman JM, Evans GR.

    J Med Genet. 2001 Nov;38(11):783-4. No abstract available. PMID: 11732488 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The genetic and molecular pathogenesis of NF1 and NF2.

    Yohay KH.

    Semin Pediatr Neurol. 2006 Mar;13(1):21-6. Review.PMID: 16818172 [PubMed - indexed for MEDLINE]Related articles

    3.

    NF2: the wizardry of merlin.

    Xiao GH, Chernoff J, Testa JR.

    Genes Chromosomes Cancer. 2003 Dec;38(4):389-99. Review.PMID: 14566860 [PubMed - indexed for MEDLINE]Related articles

    4.

    Merlin PAKs a punch.

    Widemann BC.

    Cancer J. 2004 Jan-Feb;10(1):8-11. No abstract available. PMID: 15000489 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Neurofibromatosis ]

    Wakabayashi T, Saito K, Yoshida J.

    Nippon Rinsho. 2005 Sep;63 Suppl 9:164-9. Review. Japanese. No abstract available. PMID: 16201518 [PubMed - indexed for MEDLINE]Related articles

    6.

    Neurofibromatosis type 2.

    Uppal S, Coatesworth AP.

    Int J Clin Pract. 2003 Oct;57(8):698-703. Review.PMID: 14627181 [PubMed - indexed for MEDLINE]Related articles

    7.

    Neurofibromatosis type 2.

    Thomas G, Mérel P, Sanson M, Hoang-Xuan K, Zucman J, Desmaze C, Melot T, Aurias A, Delattre O.

    Eur J Cancer. 1994;30A(13):1981-7. Review. No abstract available. PMID: 7734211 [PubMed - indexed for MEDLINE]Related articles

    8.

    Molecular insights into neurofibromatosis 2.

    Gutmann DH.

    Neurobiol Dis. 1997;3(4):247-61. Review. No abstract available. PMID: 9173923 [PubMed - indexed for MEDLINE]Related articles

    9.

    Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.

    Shimizu T, Seto A, Maita N, Hamada K, Tsukita S, Tsukita S, Hakoshima T.

    J Biol Chem. 2002 Mar 22;277(12):10332-6. Epub 2001 Dec 27.PMID: 11756419 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

    Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lázaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG.

    J Med Genet. 2005 Jul;42(7):540-6. Review.PMID: 15994874 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Vascular dysplasia in neurofibromatosis type 2.

    Ryan AM, Hurley M, Brennan P, Moroney JT.

    Neurology. 2005 Jul 12;65(1):163-4. No abstract available. PMID: 16009910 [PubMed - indexed for MEDLINE]Related articles

    12.

    Neurofibromatosis.

    McClatchey AI.

    Annu Rev Pathol. 2007;2:191-216. Review.PMID: 18039098 [PubMed - indexed for MEDLINE]Related articles

    13.

    Neurofibromatosis 2.

    Kitamura K, Takahashi K, Kakoi H.

    Adv Otorhinolaryngol. 2000;56:244-8. Review. No abstract available. PMID: 10868241 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.

    Surace EI, Haipek CA, Gutmann DH.

    Oncogene. 2004 Jan 15;23(2):580-7.PMID: 14724586 [PubMed - indexed for MEDLINE]Related articles

    15.

    Isolation and characterization of an aggresome determinant in the NF2 tumor suppressor.

    Gautreau A, Fievet BT, Brault E, Antony C, Houdusse A, Louvard D, Arpin M.

    J Biol Chem. 2003 Feb 21;278(8):6235-42. Epub 2002 Dec 5.PMID: 12471027 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Serial analysis of gene expression in neurofibromatosis type 2-associated vestibular schwannoma.

    Halum SL, Popper P, Cioffi JA, Wackym PA.

    Otol Neurotol. 2004 Jul;25(4):587-93.PMID: 15241239 [PubMed - indexed for MEDLINE]Related articles

    17.

    A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor.

    Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M, Xiao GH, Testa JR, Wood J, Maruta H.

    Cancer J. 2004 Jan-Feb;10(1):20-6.PMID: 15000491 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Neurofibromatosis type 2]

    Hishii M, Sato K.

    Nippon Rinsho. 2000 Jul;58(7):1430-3. Review. Japanese. No abstract available. PMID: 10921318 [PubMed - indexed for MEDLINE]Related articles

    19.

    Magic but treatable? Tumours due to loss of merlin.

    Hanemann CO.

    Brain. 2008 Mar;131(Pt 3):606-15. Epub 2007 Oct 16. Review.PMID: 17940085 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.

    Diebold R, Bartelt-Kirbach B, Evans DG, Kaufmann D, Hanemann CO.

    J Mol Diagn. 2005 Feb;7(1):97-104.PMID: 15681480 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity